Correction: PAMAM/5-fluorouracil drug conjugate for targeting E6 and E7 oncoproteins in cervical cancer: a combined experimental/in silico approach (RSC Adv. (2017) 7 (5046-5054) DOI: 10.1039/C6RA26511A)

Arunkumar Rengaraj, Balaji Subbiah, Yuvaraj Haldorai, Dhanusha Yesudhas, Hyung Joong Yun, Soonjo Kwon, Sangdun Choi, Young Kyu Han, Eung Soo Kim, Hema Shenpagam N., Yun Suk Huh

Research output: Contribution to journalComment/debate

4 Scopus citations

Abstract

Correction for ‘PAMAM/5-fluorouracil drug conjugate for targeting E6 and E7 oncoproteins in cervical cancer: a combined experimental/in silico approach’ by Arunkumar Rengaraj et al., RSC Adv., 2017, 7, 5046-5054.

Original languageEnglish
Pages (from-to)11281
Number of pages1
JournalRSC Advances
Volume7
Issue number19
DOIs
StatePublished - 2017

Fingerprint

Dive into the research topics of 'Correction: PAMAM/5-fluorouracil drug conjugate for targeting E6 and E7 oncoproteins in cervical cancer: a combined experimental/in silico approach (RSC Adv. (2017) 7 (5046-5054) DOI: 10.1039/C6RA26511A)'. Together they form a unique fingerprint.

Cite this